LightNews LightNews
drsophiemerrick.bsky.social
@drsophiemerrick.bsky.social
32 followers 24 following 4 posts
Posts Replies Media Videos
Reposted
mrcctu.bsky.social
Dr Sophie Merrick (@drsophiemerrick.bsky.social) presented at #ESMO25 results from her qualitative study within the RAMPART #ClinicalTrial.

Her research highlights how immunotherapy impacts the lives of kidney cancer patients, an essential view in cancer care.

🔗 View the poster: buff.ly/fPtvyZ2
A photo of Sophie standing in front of her poster at the ESMO conference 2025
November 3, 2025 at 11:34 AM
Reposted
mrcctu.bsky.social
📈 Exciting news from #ESMO25!

First results from the RAMPART trial show that a combination of 2 immunotherapy drugs (durvalumab and tremelimumab) helps prevent kidney cancer from coming back after surgery.

🔗 Read the full story: www.mrcctu.ucl.ac.uk/news/news-st...
A combination of two immunotherapy drugs benefits people with kidney cancer | MRC Clinical Trials Unit at UCL
www.mrcctu.ucl.ac.uk
October 21, 2025 at 8:15 AM
Reposted
mrcctu.bsky.social
Another Wednesday, another chance to share what makes us proud! 😊

This week, we’re spotlighting Sophie Merrick drsophiemerrick.bsky.social, one of our Senior Clinical Research Fellows at the Unit.

Here’s what Sophie is #ProudestOf from the Unit’s work 👇
A card with a quote from Sophie, it reads, "I'm proud that the work we're doing helps people with cancer live better, not just longer. The REFINE trial, for example, is focused on improving patients' quality of life and making cancer treatment more accessible and equitable around the world."
August 6, 2025 at 8:07 AM
Reposted
mrcctu.bsky.social
💻 Come along to our next Capacity Strengthening Hub webinar with @tghn-news.bsky.social to hear about experts' experience, general principles and a practical framework for communicating #ClinicalTrials results with participants.

🗓️ 2 June
🕙 10:00-11:30 BST
📍 Online

Register now: bit.ly/4k28ALd
May 5, 2025 at 11:02 AM
drsophiemerrick.bsky.social
Join us for our next @NIHRresearch
Learning Lecture 'Making Clinical Trials More Inclusive' with @kamleshkhunti

⏰ 11th June 1-2pm
🖥️ Online
💷 Free

Sign up 👇
sites.google.com/nihr.ac.uk/a...
Associate Principal Investigator Scheme - Schedule
Next lecture
sites.google.com
May 16, 2025 at 10:14 AM
drsophiemerrick.bsky.social
'The words "tolerable" or "tolerability" should not be used unless quality of life data are reported' #QoLConf25
May 12, 2025 at 11:20 AM
drsophiemerrick.bsky.social
Pleased to share our most recent paper on 'Determining the optimal use of approved drugs in oncology' which is now published in Lancet Oncology. Check it out h👇
mrcctu.bsky.social MRC Clinical Trials Unit at UCL @mrcctu.bsky.social · May 6
Optimising use of drugs requires evidence from post-approval #ClinicalTrials that test different uses.

This new paper helps prioritise research questions aimed at getting the most out of approved #cancer drugs, considering perspectives of patients, clinicians & funders. #OncSky

bit.ly/42OiGcU
bit.ly
May 7, 2025 at 11:30 AM
drsophiemerrick.bsky.social
Join us next week for our free @nihr.bsky.social webinar 'Clinical trials aimed at optimising approved drugs'

⏰ Thursday 20.2.25 1-2pm
💷 Free
👇 Sign up here

@mrcctu.bsky.social

sites.google.com/nihr.ac.uk/a...
Associate Principal Investigator Scheme - Schedule
Next lecture
sites.google.com
February 10, 2025 at 9:40 PM
Reposted
annabellesouth.bsky.social
Are you a member of a Research Ethics Committee in the UK? If so, we'd love to speak to you about your views of personalised trials in mental health. Please do consider signing up. #ResearchEthics #MentalHealth
mrcctu.bsky.social MRC Clinical Trials Unit at UCL @mrcctu.bsky.social · Jan 8
Can you help us improve #MentalHealth research?

Find out more or help us spread the word to healthcare professionals, mental health app developers, or research ethics committee members. www.mrcctu.ucl.ac.uk/n-of-1

#Medsky #Nursesky #Psychsky
February 7, 2025 at 11:35 AM
Reposted
sdanson1.bsky.social
This is brilliant news for the post NCRI oncology world
amrc-uk.bsky.social Association of Medical Research Charities @amrc-uk.bsky.social · Feb 4
Today, on #WorldCancerDay, a new UK Collaborative for Cancer Clinical Research has launched. It will support charities to convene expertise from across the cancer research landscape, to identify strategic priorities and cross-cutting areas of unmet need. bit.ly/3WN4PQm
“Charities provide two thirds of public investment in cancer research in the UK. The UK Collaborative for Cancer Clinical Research, hosted by the AMRC, will support cancer charities in bringing together their clinical research communities and making connections. The Collaborative will also help to identify joint priorities, tackle shared challenges and maximise opportunities for innovation.”
February 7, 2025 at 3:24 PM
Reposted
mrcctu.bsky.social
Fraudulent participation is when study participants purposely give false responses. This can be common in qualitative studies using online recruitment & monetary incentives.

The P-FROST recommendations provide advice on this emerging phenomenon.👇https://buff.ly/4j2qYnl @drsophiemerrick.bsky.social
Fraudulent Participation in Online Qualitative Studies: Practical Recommendations on an Emerging Phenomenon
This paper offers a critical reflection thereon by three separate qualitative research groups that experienced fraudulent participation in collaboration with a patient representative, a bioethicist, a legal expert, a journal deputy editor, and a chief executive of a national charity.
buff.ly
January 16, 2025 at 12:00 PM
Reposted
annabellesouth.bsky.social
Late-phase clinical trials have the potential to improve health, but there are often delays in these results influencing clinical practice. We developed a knowledge transfer and exchange strategy to help reduce these delays and maximise impact link.springer.com/article/10.1...
Developing a knowledge transfer and exchange strategy for a clinical trials unit - Trials
Need for a strategic approach to knowledge transfer and exchange Late-phase clinical trials and systematic reviews find results that have the potential to improve health outcomes for people. However, ...
link.springer.com
January 6, 2025 at 8:49 AM